Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Trulicity (dulaglutide) is a GLP-1 receptor agonist administered as a once-weekly subcutaneous injection for type 2 diabetes management
Several large clinical trials have demonstrated that GLP-1 receptor agonists can reduce the risk of cardiovascular events, such as heart attacks and strokes, in people with type 2 diabetes who are at high risk for heart disease
Zepbound is recommended for weight management, while Mounjaro is suitable for blood sugar control
Made for human use
US$ 23.13
US$ 22.40
US$ 29.44
US$ 28.35
US$ 25.43
